Opening session
Welcome and Introduction
Silvia C. Formenti Weill Cornell Medicine New York, NY, USA
Jedd Wolchok Weill Cornell Medicine New York, NY, USA
Three days of scientific discussions, keynote lectures and expert sessions dedicated to radiation therapy, nuclear medicine and anti-tumor immunity.
Download the program September 23–25, 2026 Three-day scientific program
New York, USA Medical scientific meeting
Day 1
2:00 pm – 6:30 pmWednesday, September 23, 2026
Keynote Lecture
Chair: Silvia C. Formenti Theranostics and Nuclear Medicine
Evolving role of theranostics for imaging and treatment of prostate cancer
Robert Flavell University of California, San Francisco San Francisco, CA, USA
Main Program
Session I
Radionuclide Therapy and Anti-Tumor Immunity
Chairs: Bhadrasain Vikram and Claire Vanpouille-Box
Phase I/II of a FAP-targeted radiopharmaceutical for sarcomas
John Babich Ratio Therapeutics, Inc. Boston, MA, USA
Adapting radiopharmaceutical therapy dosing to maximize response in combination with immunotherapies
Zachary Morris University of Wisconsin Madison, WI, USA
PARP-targeted theranostic approach to image and treat ovarian cancer
Sarah Gitto University of Pennsylvania Philadelphia, PA, USA
Selected abstract
Establishment and optimization of a preclinical platform for evaluating the novel CD44v6-targeted radiopharmaceutical [177Lu]Lu-AKIR001 in combination with anti-CD47 immunotherapy for gastrointestinal cancers
Amanda Gustafsson Uppsala University Uppsala, Sweden
Coffee Break 4:30 pm – 5:00 pm
Session II
Imaging Radiation-Induced Immune Response
Chairs: Michelle Bradbury and James Kelly
Radiomics-based imaging of radiation-induced immune modulation
Eric Deutsch Gustave Roussy Paris, France
CD8 immunoPET for imaging immune responses to radiation
Anna Wu City of Hope Los Angeles, CA, USA
Imaging-guided radioligand therapy in glioblastoma: from precision targeting to treatment response.
Gabriela Kramer-Marek Institute for Cancer Research London, UK
Selected abstract
PET Tracking of Engineered CD70-Targeting CAR-NK Cells Using Radiohapten Capture In Vivo
Céline Chevaleyre University of Texas MD Anderson Cancer Center Houston, TX, USA
6:30 pm End of Day 1
Day 2
8:30 am – 8:30 pm Thursday, September 24, 2026
Keynote Lecture
Chair: Silvia C. Formenti Mechanisms of Immune Tolerance
Mechanisms of Immune Tolerance: Balancing Immunity and Homeostasis
Julie Magarian Blander Weill Cornell Medicine New York, NY, USA
Session III
Immune Tolerance Mechanisms, Implication for Radiation Therapy
Chairs: Lorenzo Galluzzi and Arta Monjazeb
Interception, REstitution, and Prevention - IREP for Immunity
Michael Lotze University of Pittsburgh Pittsburgh, PA, USA
Thymus Health and Immune Fitness
Silvia C. Formenti Weill Cornell Medicine New York, NY, USA
AI tool to measure thymic health
Aaron Berliner Weill Cornell Medicine New York, NY, USA
Macrophages and Radiation
Nir Ben Chetrit Weill Cornell Medicine New York, NY, USA
Coffee Break 10:45 am – 11:15 am
Session IV
Immune Effects of Radiation in the Clinic: Contributions from the ROBIN Centers
Chairs: Jeffrey Buchsbaum and Joseph Deasy
ImmunoRad ROBIN
Encouse Golden Weill Cornell Medicine New York, NY, USA
Chemoradiation reprograms myeloid cells in the tumor microenvironment
Julie Schwarz Washington University School of Medicine St. Louis, MO, USA
Optimizing Radiation in the Context of Preoperative Immune Therapy in Head and Neck Cancer
Jonathan Schoenfeld Harvard Medical School Boston, MA, USA
GenRad ROBIN
Timothy Chan Cleveland Clinic Cleveland, OH, USA
Oligometastasis (OligoMET) Center: Using Biomarker Correlates from Prostate Cancer Clinical Trials to Improve Future Outcomes
Chad Tang University of Texas MD Anderson Cancer Center Houston, TX, USA
Discussion
Q&A
Lunch Break 1:15 pm – 2:15 pm
Session V
How to Harness RT to Potentiate an Immune Response
Chairs: Encouse Golden and Andy Minn
Immunotherapy and Radiation: Navigating the Benefits and Challenges
Sana Karam Washington University School of Medicine St. Louis, MO, USA
Radiotherapy and Immune Checkpoint Blockade: Lessons from the UC Davis Experience
Arta Monjazeb UC Davis Health Sacramento, CA, USA
Modulators of Radiation-Immunotherapy Synergy in Breast Cancer
Gaorav Gupta University of North Carolina at Chapel Hill Chapel Hill, NC, USA
Selected abstract
Immune Dynamics and Determinants of SABR and Anti-PD-1 Response in Metastatic ccRCC: Insights from the RAPPORT Trial
Van To University of Melbourne Melbourne, VIC, Australia
Coffee Break 3:45 pm – 4:05 pm
Session VI
Normal Tissue vs. Tumor Response to Radiation
Chairs: Sana Karam and Bo Lu
Radiotherapy-induced remodeling of the glioblastoma microenvironment as a therapeutic vulnerability
Alexander Pietras Lund University Lund, Sweden
The Impact of FLASH Radiotherapy on the Immune Environment of Normal and Tumor Tissues: A Window for Therapeutic Exploitation
Constantinos Koumenis University of Pennsylvania Philadelphia, PA, USA
FLASH-based radioimmunotherapy in brain tumor
Yi Fan University of Pennsylvania Philadelphia, PA, USA
Selected abstract
Biodosimetric evaluation of the LymphoDose framework: first comparison of a mechanistic lymphocyte dose model against cytogenetic dosimetry
Hacene Bekkar Gustave Roussy Paris, France
Panel Discussion
Intratumoral Immunotherapy with Radiation Therapy to Enhance Anti-Tumor Immunity
Chairs: Sandra Demaria and James Welsh
5:35 pm – 6:30 pm
Sana Karam Washington University St. Louis, MO, USA
Howard Kaufman Ankyra Therapeutics Cambridge, MA, USA
Aisha Hasan Johnson & Johnson USA
Taha Merghoub Weill Cornell Medicine New York, NY, USA
6:30 pm to 8:30 pm
Networking Poster Session
Scientific posters, discussions and networking.
Day 3
8:30 am – 9:00 pm Friday, September 25, 2026
Keynote Lecture
Spooky action at a distance
Chair: Claire Vanpouille-Box
Spooky action at a distance
Ralph Weischelbaum University of Chicago Chicago, IL, USA
Session VII
Innate Immunity and Radiation Therapy
Chairs: Wen Shen and Claire Vanpouille-Box
Smart Synergy: combining radiation and artificial intelligence to unlock immunotherapy response
James Welsh University of Texas MD Anderson Cancer Center Houston, TX, USA
Apoptotic competence regulates innate immune signaling in irradiated cancer cells
Lorenzo Galluzzi Fox Chase Cancer Center Philadelphia, PA, USA
Type I interferon in Radiation Therapy: Friend or Foe?
Andy Minn Memorial Sloan Kettering New York, NY, USA
Selected abstract
Proton therapy triggers transposable element-mediated IFN-I signaling to promote tissue regeneration
Lara Barazzuol University Medical Center Groningen Groningen, Netherlands
Selected abstract
Multi-site SBRT and intratumoral IL-12 effectively treats metastatic PDAC
Gary Hannon University of Rochester Medical Center Rochester, NY, USA
Coffee Break 11:00 am – 11:30 am
Session VIII
The Microbiome in the Context of Radiation
Chairs: Sandra Demaria and Rie Nygaard
Interplay between the microbiota, metabolites, and cancer immunosurveillance
Marine Fidelle Gustave Roussy Paris, France
Microbiome regulation of anti-tumor immunity elicited by radiation
Stephen Shiao Cedars-Sinai Los Angeles, CA, USA
Microbiome-Driven Immune Programming of Radiotherapy Responses
Andrea Facciabene University of Pennsylvania Philadelphia, PA, USA
Lunch Break 12:45 pm – 2:30 pm
Session IX
Role of Radiation in Cell Therapy
Chairs: Juan Cubillos-Ruiz and Joshua Fein
Radiation Induced Immune Dysfunction
Chandan Guha Albert Einstein College of Medicine New York, NY, USA
Enhancing CAR T-Cell Efficacy in Lymphoma with Low-Dose Irradiation
Monica Guzman Weill Cornell Medicine New York, NY, USA
Targeting Immune Modulation with CAR-T/CAAR-T to Reduce Autoimmune Toxicities
Bo Lu University of Missouri Columbia, MO, USA
Selected abstract
Radiation Induces CAR-T Target Antigen Expression and Upregulates Fas/TRAIL Pathway in Aggressive B Cell Lymphoma
Nourhan G. Ahmed University of Texas MD Anderson Cancer Center Houston, Texas
Panel Discussion
Artificial Intelligence in Radiation and Immunotherapy
Chairs: Olivier Elemento and Liron Yoffe
4:00 pm – 5:00 pm
James Welsh MD Anderson Cancer Center Houston, TX, USA
Akshay Nanduri Onc AI San Francisco, CA, USA
Joseph Deasy Memorial Sloan Kettering New York, NY, USA
Aaron Berliner Weill Cornell Medicine New York, NY, USA
5:00 pm – 5:15 pm Concluding Remarks — Eric Deutsch
5:15 pm End of Day 3
Thank you to our sponsors and contributors
We sincerely thank our sponsors and contributors for their valuable support
and contribution to the success of ImmunoRad.
GOLD SPONSOR
Other Contributors
© IMMUNORAD 2026®, Créé par CED-WEB
